# Comparison of the Effects of Tapentadol and Oxycodone on Gastrointestinal and Colonic Transit in Humans

> **NCT01500317** · PHASE4 · COMPLETED · sponsor: **Mayo Clinic** · enrollment: 38 (actual)

## Conditions studied

- Effects of 2 Mu-opiates on Gastrointestinal Transit

## Interventions

- **DRUG:** Tapentadol
- **DRUG:** Oxycodone
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01500317
- **Lead sponsor:** Mayo Clinic
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-05
- **Primary completion:** 2011-10
- **Final completion:** 2011-12
- **Target enrollment:** 38 (ACTUAL)
- **Last updated:** 2012-12-17

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01500317

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01500317, "Comparison of the Effects of Tapentadol and Oxycodone on Gastrointestinal and Colonic Transit in Humans". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT01500317. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*